Indications

• Prostate Cancer (see Prostate Cancer, [[Prostate Cancer]])

---

Pharmacology

• xxx

---

Administration

• PO:

---

Adverse Effects

Pulmonary Adverse Effects

• Interstitial Pneumonitis (see Interstitial Lung Disease-Etiology, [[Interstitial Lung Disease-Etiology]])
• Drug-Induced Pulmonary Eosinophilia (see Drug-Induced Pulmonary Eosinophilia, [[Drug-Induced Pulmonary Eosinophilia]])

Other Adverse Effects

• xxxx

---

References

• Interstitial pneumonitis associated with neoadjuvant leuprolide and nilutamide for prostate cancer. J Urol. 1998 Jun;159(6):2099 [MEDLINE]
• Interstitial pneumonitis related to leuprorelin acetate and flutamide. J Urol. 1999 Jan;161(1):221 [MEDLINE]
• Interstitial pneumonitis induced by bicalutamide and leuprorelin acetate for prostate cancer. Int J Urol. 2003 Nov;10(11):625-6 [MEDLINE]